Welcome to our dedicated page for Zentek news (Ticker: ZTEK), a resource for investors and traders seeking the latest updates and insights on Zentek stock.
Zentek Ltd. develops and commercializes graphene-enabled and advanced material technologies through platforms that include ZenGUARD™, Albany Graphite and Triera. Company developments center on ZenGUARD™ enhanced air filters and related regulatory classification, commercialization pathways and HVAC supply-chain opportunities.
Recurring updates also cover the Albany Graphite Project in Ontario, including technical studies, environmental and social baseline work, market analysis and high-purity graphite positioning for nuclear, defence, battery and industrial markets. Triera Biosciences updates focus on aptamer discovery, biosensor enablement, machine-learning classification and infectious-disease applications, alongside material agreements, capital-structure disclosure, governance matters and operating results.
Zentek (NASDAQ:ZTEK) provided a PDAC 2026 update covering government and First Nations engagement during the March 1-4 convention in Toronto. The company attended the TSX Canadian Mining Roundtable on March 2, held meetings with federal and provincial representatives and Invest Ontario, and advanced collaboration with Constance Lake First Nation for the Albany Graphite Project.
Zentek said discussions advanced Albany's positioning for critical-minerals funding frameworks and planning toward environmental baseline studies and a new Preliminary Economic Assessment.
Zentek (NASDAQ:ZTEK) initiated an 8–12 week pilot evaluation with Quality Filters to test integration of Zentek's proprietary air filtration media into Quality's commercial HVAC and industrial filter lines. The pilot will assess compatibility, manufacturing scalability, and real‑world performance as a step toward a potential long‑term supply or licensing arrangement.
The pilot supports Zentek's IP‑integration commercialization pathway and runs in parallel with U.S. regulatory evaluation and an existing royalty arrangement with Altek.
Zentek (NASDAQ:ZTEK) outlines government engagement and plans to advance the Albany Graphite Project toward a Pre-Feasibility Study (PFS). Key actions include commissioning a new Preliminary Economic Assessment this fiscal quarter, initiating second-year environmental baseline work, advancing FBR purification engineering, and pursuing non-dilutive federal and provincial funding.
Albany has laboratory-scale nuclear-grade results (99.9992% purity; 2.60 ppm boron) and is positioned to access programs such as Canada's $2-billion Strategic Resource Fund and Ontario's $500 million Critical Minerals Processing Fund.
Zentek (NASDAQ: ZTEK) was granted a 180‑day extension to regain compliance with Nasdaq's $1.00 minimum bid price rule, extending the cure period to August 24, 2026. The company must maintain a closing bid of at least $1.00 for ten consecutive business days on or before that date. There is no immediate effect on listing or trading; shares will continue to trade under ZTEK. Management says it will monitor the bid price and consider available options to regain compliance.
Zentek (NASDAQ:ZTEK) outlined a strategic reset focused on three core platforms: Albany Graphite, ZenGUARD and Triera, with milestone-based capital allocation, cost reductions, and pause of non-core work.
Key technical news: independent labs show Albany graphite can reach 5N (99.9992%) purity with 2.60 ppm boron, meeting the sub-3 ppm nuclear threshold. Near-term steps include an updated PEA, pilot-scale processing, environmental baseline work with Constance Lake First Nation, and options to spin out or partner within 12–18 months. Health Canada currently treats ZenGUARD Enhanced Air Filters as pest control products, and Zentek continues to submit data and evaluate label or market options.
Zentek (NASDAQ: ZTEK) announced a strategic reset on January 29, 2026, narrowing focus to three core platforms: Albany Graphite, ZenGUARD, and Triera, each managed to defined milestones with a 24-month roadmap.
The company said it will pause non-core initiatives, reduce costs via workforce and facility optimization, tighten corporate spending, and link future capital raises to specific milestones. The Chief Science Officer, Colin van der Kuur, has departed and responsibilities were redistributed across technical leadership. Zentek said it will increase segment-level disclosure and milestone tracking.
Zentek (Nasdaq:ZTEK) said subsidiary Albany Graphite achieved ultra-high purity—five‑nines (99.9992%) with an equivalent boron concentration of 2.60 ppm—meeting the <3 ppm threshold commonly referenced for nuclear applications. Independent lab tests of near‑net‑shaped graphite bricks confirmed finished components met key nuclear‑grade benchmarks for strength, density, electrical performance and impurity levels.
Management cites a growing ultra‑high‑purity graphite market (estimated 10.5% CAGR to 2030) and projects potential demand of 100,000–200,000 tonnes/year of purified natural high‑purity graphite over 15–20 years, positioning Albany as a potential North American supplier for nuclear, defense, aerospace and premium battery markets.
Zentek (Nasdaq:ZTEK) reported that subsidiary Albany Graphite achieved near-theoretical anode performance in independent lithium-ion coin cell tests on December 17, 2025. Carbon-coated, spheroidized Albany graphite delivered an average reversible capacity of 367.35 mAh/g, ~1.3% below the 372 mAh/g theoretical maximum, with average capacity retention >b>94% versus Li/Li+ over ~110–120 cycles and irreversible capacity loss of 7.0%–8.3%. Tests used industry-standard C/10 rate and electrode loadings near 10 mg/cm². A 50/50 blend of spheroidization rejects with NMC622 performed comparably as a conductive additive, suggesting higher yield and process efficiency for battery-grade graphite production.
Zentek (Nasdaq: ZTEK) appointed Mohammed (Moe) Jiwan as Chief Executive Officer and director, effective December 1, 2025. The board thanked Wendy Ford for her interim CEO leadership and confirmed she will continue as Chief Financial Officer. The company granted, effective November 25, 2025, (i) 475,000 stock options at $1.06 per share for three years with staged vesting and a four-month hold period, and (ii) 425,000 restricted share units vesting on December 1, 2026. Management said the CEO hire is intended to drive commercialization, secure capital, and unlock value from the company’s technologies and assets.
Zentek (NASDAQ:ZTEK) received a Canada Revenue Agency notice of reassessment dated October 8, 2025 related to the company's 2019 year and two flow-through financings that closed Dec 21, 2018 and Dec 20, 2019 for gross proceeds of $4,210,000.
CRA reclassified approximately $199,000 (16.467%) of renounced amounts as non-CEE, producing a Part XII.6 tax assessment of $22,481.89. Subscribers will be contacted by CRA about reduced deductions and reassessments.
Under subscription agreements, Zentek must indemnify affected subscribers within 20 business days, with a maximum aggregate indemnity exposure of $427,000.